117 related articles for article (PubMed ID: 4068004)
1. Antiandrogenic activity of a series of des-A-steroid derivatives.
Morales-Alanis H; Brienne MJ; Jacques J; Bouton MM; Nédélec L; Torelli V; Tournemine C
J Med Chem; 1985 Dec; 28(12):1796-803. PubMed ID: 4068004
[TBL] [Abstract][Full Text] [Related]
2. Relative binding affinity of novel steroids to androgen receptors in hamster prostate.
Cabeza M; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Rojas A; Orozco A; Mungía A; Agustín G; Cuatepotzo L; Gonzalez C; Palma S; Padilla D; Perez V; Jimenez G
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):357-64. PubMed ID: 16206830
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.
Teutsch G; Goubet F; Battmann T; Bonfils A; Bouchoux F; Cerede E; Gofflo D; Gaillard-Kelly M; Philibert D
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):111-9. PubMed ID: 8136296
[TBL] [Abstract][Full Text] [Related]
4. Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives.
Bratoeff EA; Herrera H; Ramírez E; Solorzano K; Murillo E; Quiróz A; Cabeza M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1249-55. PubMed ID: 10993221
[TBL] [Abstract][Full Text] [Related]
5. Antiandrogenic effect of new synthetic steroids.
Cabeza M; Quiroz A; Heuze I; Bratoeff E; Herrera H; Ramírez E; Murillo E
Proc West Pharmacol Soc; 2000; 43():31-2. PubMed ID: 11056950
[TBL] [Abstract][Full Text] [Related]
6. [Anti-androgenic activity of various substituted carboxyanilides].
Varga SV; Reznikov AG; Bal'on IaG; Lozinskiĭ MO; Smirnov VA
Probl Endokrinol (Mosk); 1983; 29(2):67-71. PubMed ID: 6856597
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of 4-halo progesterone derivatives as antiandrogen.
Cabeza M; Quiroz A; Bratoeff E; Murillo ME; Ramírez E; Flores G
Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1232-6. PubMed ID: 10517005
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic steroidal sulfonylpyrazoles.
Christiansen RG; Bell MR; D'Ambra TE; Mallamo JP; Herrmann JL; Ackerman JH; Opalka CJ; Kullnig RK; Winneker RC; Snyder BW
J Med Chem; 1990 Aug; 33(8):2094-100. PubMed ID: 2374140
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
Stárka L; Hampl R; Kasal A; Kohout L
J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
[TBL] [Abstract][Full Text] [Related]
10. New aromatic esters of progesterone as antiandrogens.
Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of new 16-methyl pregnane derivatives.
Ramirez E; Cabeza M; Heuze I; Gutiérrez E; Bratoeff E; Membrillo M; Lira A
Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):15-20. PubMed ID: 11824579
[TBL] [Abstract][Full Text] [Related]
13. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
[TBL] [Abstract][Full Text] [Related]
14. Towards the mapping of the progesterone and androgen receptors.
Ojasoo T; Delettré J; Mornon JP; Turpin-VanDycke C; Raynaud JP
J Steroid Biochem; 1987; 27(1-3):255-69. PubMed ID: 3695484
[TBL] [Abstract][Full Text] [Related]
15. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
[TBL] [Abstract][Full Text] [Related]
16. [Development of nonsteroidal antiandrogens: 4-nitro-3-trifluoromethyldiphenylamines].
Humm AW; Schneider MR
Arch Pharm (Weinheim); 1990 Feb; 323(2):83-7. PubMed ID: 2159274
[TBL] [Abstract][Full Text] [Related]
17. Steroids with modified ring A or B: screening for potential antiandrogenic and synandrogenic activity.
Stárka L; Hampl R; Bicíková M; Cerný V; Fajkos J; Kasal A; Kocovský P; Kohout L; Velgová H
J Steroid Biochem; 1980 Apr; 13(4):455-60. PubMed ID: 7190203
[No Abstract] [Full Text] [Related]
18. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
19. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
[TBL] [Abstract][Full Text] [Related]
20. Antiandrogen. II. Oxygenated 2-oxapregnane steroids.
Takegawa S; Koizumi N; Takahashi H; Shibata K
Chem Pharm Bull (Tokyo); 1993 May; 41(5):870-5. PubMed ID: 7687931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
